HLA Class II Antigen Expression in Colorectal Carcinoma Tumors as a Favorable Prognostic Marker
Open Access
- 1 January 2014
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 16 (1), 31-W15
- https://doi.org/10.1593/neo.131568
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- High Myeloperoxidase Positive Cell Infiltration in Colorectal Cancer Is an Independent Favorable Prognostic FactorPLOS ONE, 2013
- Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancerJournal of Translational Medicine, 2011
- Molecular Genetics of Colorectal CancerAnnual Review Of Pathology-Mechanisms Of Disease, 2011
- The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancerBritish Journal of Cancer, 2010
- Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinomaInternational Journal of Cancer, 2010
- Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genesInternational Journal of Cancer, 2009
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- Cancer-related inflammationNature, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998